Institute of Psychiatric Research, Department of Psychiatry, Indiana University School of Medicine, 791 Union Drive, Indianapolis, IN 46202-4887, USA.
J Pharmacol Exp Ther. 2012 Jan;340(1):202-9. doi: 10.1124/jpet.111.187245. Epub 2011 Oct 19.
Ethanol (EtOH) and cocaine are both self-administered into the posterior ventral tegmental area (VTA). Self-administration of either drug is prevented by coadministration of a serotonin (5-HT₃) receptor antagonist. Electrophysiological studies indicated that cocaine and EtOH can act synergistically to stimulate VTA dopamine neurons. The current experiment assessed whether cocaine and EtOH would synergistically interact to produce a reinforcing action within the posterior VTA. Adult female Wistar rats were randomly assigned to one of 13 groups. There were three control groups: artificial cerebrospinal fluid (aCSF), a subthreshold EtOH (100 mg%) group, and a subthreshold cocaine (25 pmol/100 nl) group. The other groups self-administered 50 or 75 mg% EtOH containing 6.25, 12.5, or 25 pmol/100 nl cocaine or 100 mg% EtOH containing 3.12, 6.25, 12.5, or 25 pmol/100 nl cocaine. All rats received the assigned infusate for sessions 1 through 4, aCSF alone in sessions 5 and 6, and the original infusate during session 7. The effects of adding a 5-HT₃ receptor antagonist [tropisetron, C₁₇H₂₀N₂O₂ (ICS 205,930) and C₁₇H₂₂N₄O.C₄H₄O₄ (LY278-584)] on coadministration of EtOH and cocaine (75 mg% + 12.5 pmol/100 nl) were determined. Rats failed to self-administer aCSF or the subthreshold concentration of EtOH or cocaine. All three concentrations of EtOH (50, 75, and 100 mg%) combined with cocaine (12.5 and 25 pmol/100 nl) supported self-administration. Adding a 5HT₃ receptor antagonist attenuated coadministration of EtOH + cocaine. Overall, the data indicate that the reinforcing properties of EtOH and cocaine interacted synergistically within the posterior VTA, and these synergistic effects were mediated, at least in part, by activation of local 5-HT₃ receptors.
乙醇(EtOH)和可卡因都可被自行注射到腹侧被盖区(VTA)的后部。5-羟色胺(5-HT₃)受体拮抗剂的共同给药可防止这两种药物的自我给药。电生理学研究表明,可卡因和 EtOH 可以协同刺激 VTA 多巴胺神经元。目前的实验评估了可卡因和 EtOH 是否会协同作用,从而在 VTA 后部产生强化作用。成年雌性 Wistar 大鼠被随机分配到 13 组中的一组。有三个对照组:人工脑脊液(aCSF)、亚阈值 EtOH(100mg%)组和亚阈值可卡因(25pmol/100nl)组。其他组自行注射含有 6.25、12.5 或 25pmol/100nl 可卡因的 50 或 75mg%EtOH,或含有 3.12、6.25、12.5 或 25pmol/100nl 可卡因的 100mg%EtOH。所有大鼠在第 1 至 4 节接受指定的输注,在第 5 和 6 节接受单独的 aCSF,在第 7 节接受原始的输注。添加 5-羟色胺(5-HT₃)受体拮抗剂[tropisetron,C₁₇H₂₀N₂O₂(ICS 205,930)和 C₁₇H₂₂N₄O.C₄H₄O₄(LY278-584)]对 EtOH 和可卡因(75mg%+12.5pmol/100nl)共同给药的影响。大鼠未能自行注射 aCSF 或亚阈值浓度的 EtOH 或可卡因。三种浓度的 EtOH(50、75 和 100mg%)与可卡因(12.5 和 25pmol/100nl)联合支持自我给药。添加 5-HT₃ 受体拮抗剂减弱了 EtOH+可卡因的共同给药。总的来说,数据表明,EtOH 和可卡因在 VTA 后部的强化作用具有协同作用,这些协同作用至少部分是通过激活局部 5-HT₃ 受体介导的。